Glenmede Trust’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,406
| Closed | -$246K | – | 1324 |
|
|
2022
Q3 | $246K | Buy |
+4,406
| New | +$246K | ﹤0.01% | 1025 |
|
|
2022
Q2 | – | Sell |
-5,375
| Closed | -$390K | – | 1347 |
|
|
2022
Q1 | $390K | Sell |
5,375
-51
| -0.9% | -$3.7K | ﹤0.01% | 970 |
|
|
2021
Q4 | $641K | Sell |
5,426
-518
| -9% | -$61.2K | ﹤0.01% | 856 |
|
|
2021
Q3 | $797K | Sell |
5,944
-452
| -7% | -$60.6K | ﹤0.01% | 764 |
|
|
2021
Q2 | $1.03M | Sell |
6,396
-2,189
| -25% | -$354K | 0.01% | 697 |
|
|
2021
Q1 | $688K | Sell |
8,585
-283
| -3% | -$22.7K | ﹤0.01% | 754 |
|
|
2020
Q4 | $481K | Hold |
8,868
| – | – | ﹤0.01% | 851 |
|
|
2020
Q3 | $175K | Sell |
8,868
-3,078
| -26% | -$60.7K | ﹤0.01% | 1047 |
|
|
2020
Q2 | $249K | Buy |
11,946
+4,399
| +58% | +$91.7K | ﹤0.01% | 958 |
|
|
2020
Q1 | $109K | Hold |
7,547
| – | – | ﹤0.01% | 1392 |
|
|
2019
Q4 | $109K | Buy |
7,547
+4,200
| +125% | +$60.7K | ﹤0.01% | 1392 |
|
|
2019
Q3 | $43 | Buy |
3,347
+597
| +22% | +$8 | ﹤0.01% | 1727 |
|
|
2019
Q2 | $45 | Hold |
2,750
| – | – | ﹤0.01% | 1723 |
|
|
2019
Q1 | $46 | Hold |
2,750
| – | – | ﹤0.01% | 1726 |
|
|
2018
Q4 | $37 | Buy |
+2,750
| New | +$37 | ﹤0.01% | 1718 |
|
|
2018
Q3 | – | Sell |
-3,100
| Closed | -$85K | – | 1693 |
|
|
2018
Q2 | $85K | Buy |
+3,100
| New | +$85K | ﹤0.01% | 1300 |
|